eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-KYMR-Kymera Therapeutics Inc

Kymera Therapeutics Inc KYMR

‎$‎77.221.60(2.12%)(1D)
• Delayed prices by NASDAQ • in USD
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Strong Buy
Price Target
115.90
Based on analysts who covered KYMR
Invest in Kymera Therapeutics Inc
Today
Create an eToro account to buy KYMR stock on a secure, user-friendly, multi-asset trading platform.
Buy Kymera Therapeutics Inc
Kymera Therapeutics Inc KYMR
Buy KYMR

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Kymera Therapeutics Inc News

KYMR Stock Price Chart

‎9.26‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered by
*Past performance is not an indication of future results
Asset positive trend

The Kymera Therapeutics Inc share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Kymera Therapeutics Inc share price today is ‎$‎77.22, reflecting a ‎2.12‎% change over the last 24 hours and ‎8.46‎% over the past week. The current market capitalization of KYMR is ‎$‎6.1B with an average volume in the last three months of 966375.81. The stock has a P/E ratio of -21.47 and a dividend yield of 0%. With the stock’s beta sitting at 1.68
KYMR Key Metrics
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
‎$‎6.1B
Day’s Range
i
Shows the high and low prices of the day.
‎$‎75.06 - ‎$‎78.39
52W Range
i
Shows the high and low prices of the last year.
‎$‎19.59 - ‎$‎102.26
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
966375.81
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-21.47
Revenue
i
The total income generated by this company’s goods and services last year.
‎$‎43.73M
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
‎$‎0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
‎$‎77.22
EPS
i
A company’s total earnings divided by the number of shares it has issued.
‎$‎-3.6
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.68

How can I buy Kymera Therapeutics Inc stocks?

To purchase Kymera Therapeutics Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Kymera Therapeutics Inc (KYMR) page and place an order to buy Kymera Therapeutics Inc.
Buy KYMR
Looking for more information? Check out our guide on Academy.
What Is Kymera Therapeutics Inc?
Kymera Therapeutics Inc is a biotech company focused on advancing the field of targeted protein degradation. Operating globally, it leverages cellular machinery to eliminate disease-causing proteins.

Working in the biotech sector, Kymera Therapeutics Inc seeks to expand drug development and discovery. It aspires to propel the treatment landscape by developing novel, small-molecule therapeutics. The company works to improve modern medicine through its proprietary Pegasus drug discovery platform.

Monitor the KYMR share price by adding it to your eToro watchlist.
CEO
Nello Mainolfi, PhD
Employees
188
Founded
2015
HQ
Watertown, Massachusetts, US
Med Tech
NASDAQ
Get Started
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2026
Top Dividend Stocks for 2026
Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.
Read More
AI Stocks Poised for Growth in 2026
AI Stocks Poised for Growth in 2026
Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Kymera Therapeutics Inc
Invest in Kymera Therapeutics Inc
Today
Create an eToro account to buy KYMR stock on a secure, user-friendly, multi-asset trading platform.
Get Started

FAQ

The current price of KYMR is ‎$‎77.22.
The average price target for Kymera Therapeutics Inc is ‎$‎115.90. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Kymera Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Kymera Therapeutics Inc is ‎$‎6.1B
Based on 13 analysts offering recommendations for KYMR in the last 3 months, the overall consensus is Strong Buy.
Daily Movers
Explore the biggest stocks movers on the market.
Buy KYMR
English (UK)English (UK)Check icon
DeutschDeutsch
FrançaisFrançais
PolskiPolski
PortuguêsPortuguês
DanskDansk
SuomiSuomi
EspañolEspañol
РусскийРусский
العربيةالعربية
NederlandsNederlands
SvenskaSvenska
RomânăRomână
ItalianoItaliano
中文中文
繁體中文繁體中文
NorskNorsk
ČeštinaČeština
Tiếng ViệtTiếng Việt
ΕλληνικάΕλληνικά
Scroll to top